| Study of Pexidartinib in Asian Subjects With Advanced Solid Tumors (NCT02734433) | Daiichi Sankyo Co., Ltd. | 2016-06-01 |
| Evaluation of D3 Receptor Occupancy Using FLUORTRIOPRIDE ([18F]FTP) PET/CT (NCT02815917) | University of Pennsylvania | 2016-06-01 |
| Dose Escalation Study of JNJ-63709178, a Humanized CD123 x CD3 DuoBody in Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML) (NCT02715011) | Janssen Research & Development, LLC | 2016-06-01 |
| Patient-individualized Peptide Vaccination Based on Tumor-specific Mutations in Children and Young Adults With Primary/Relapsed ALL (NCT03559413) | University Children's Hospital Tuebingen | 2016-06-01 |
| Fructooligosaccharides in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant (NCT02805075) | Stanford University | 2016-06-01 |
| Effect of Stimulant Drugs on Social Perception (NCT03790618) | University of Chicago | 2016-06-01 |
| HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma (NCT02836548) | The Netherlands Cancer Institute | 2016-06-01 |
| Diet-Induced Thermogenesis: A Comparison of Whole and Processed Foods (NCT02943434) | Central Washington University | 2016-06-01 |
| A Study of MG7 Redirected Autologous T Cells for Advanced MG7 Positive Liver Metastases(MG7-CART) (NCT02862704) | Xijing Hospital | 2016-06-01 |
| Safety and Immunogenicity Study of Tetanus, Diphtheria and Acellular Pertussis (Tdap) Vaccine (NCT02813486) | Green Cross Corporation | 2016-06-01 |
| A Open-label, Randomized, Crossover Study to Assess PK of Pregabalin (NCT02783183) | Yuhan Corporation | 2016-06-01 |
| Safety and Immunogenicity Study of H3N2 M2SR Monovalent Influenza Vaccine in Healthy Volunteers (NCT02822105) | FluGen Inc | 2016-06-01 |
| A Study of ARC-521 Injection in Normal Adult Volunteers and Patients With Chronic Hepatitis B (CHB) (NCT02797522) | Arrowhead Pharmaceuticals | 2016-06-01 |
| Binimetinib With Docetaxel in Treating Patients With Previously Treated, Stage IV Non-small Cell Lung Cancer (NCT02451865) | Jonsson Comprehensive Cancer Center | 2016-06-01 |
| Safety, Reactogenicity and Immunogenicity of Heat-stable Rotavirus Vaccine (HSRV) in Adults and Infants (NCT02728869) | MSD Wellcome Trust Hilleman Laboratories Pvt. Ltd. | 2016-06-01 |
| Obinutuzumab With High-dose Ibrutinib for the Treatment of Patients With Chronic Lymphocytic Leukemia With Progressive Disease on Single Agent Ibrutinib. (NCT02611908) | Michael Choi | 2016-06-01 |
| Transplantation of Microbes for Treatment of Metabolic Syndrome & NAFLD (NCT02496390) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2016-06-01 |
| A Study to Compare the Oral Bioavailability of Single Doses of Three Vapendavir Drug Formulations in Healthy Volunteers (NCT02877264) | Aviragen Therapeutics | 2016-06-01 |
| CAR T Cells for Refractory B Cell Malignancy (NCT02963038) | Hebei Senlang Biotechnology Inc., Ltd. | 2016-06-01 |
| Fecal Microbiota Transplant for Improvement of Metabolism (NCT02530385) | Massachusetts General Hospital | 2016-06-01 |
| Pharmacokinetic Study of JNJ-56021927 When Taken Orally as Tablet Formulation in Healthy Male Japanese Participants (NCT02835508) | Janssen Pharmaceutical K.K. | 2016-06-01 |
| PreventiOn of DYSbioSis Complications With Autologous FMT in AML Patients (NCT02928523) | MaaT Pharma | 2016-06-01 |
| Study of X0002 Following Escalating Single and Multiple Doses Administered as Topical Application in Healthy Volunteers (NCT02794740) | Tianjin XinChen-Techfields Pharma Co., LTD. | 2016-06-01 |
| Clinical Trial to Evaluate Drug-drug Interactions Between Darunavir/Cobicistat and Etravirine in Hiv- Infected Patients (NCT02818348) | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | 2016-06-01 |
| A Phase I Study With Lymfactin® in the Treatment of Patients With Secondary Lymphedema (NCT02994771) | Herantis Pharma Plc. | 2016-06-01 |
| A Phase I Study of Anlotinib on Pharmacokinetics to Assess the Effect of High Fat Diet in Advanced Cancer Patients (NCT02825563) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2016-06-01 |
| Study to Assess the Taste Profile of Different ALS-008176 Oral Liquid Formulations in Healthy Adult Participants (NCT02813460) | Janssen Research & Development, LLC | 2016-06-01 |
| A Study to Evaluate Safety, Tolerability and Pharmacokinetics of DA-8010 in Healthy Subjects (NCT02821312) | Dong-A ST Co., Ltd. | 2016-06-01 |
| Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction (NCT02801357) | USWM, LLC (dba US WorldMeds) | 2016-06-01 |
| Buprenorphine Used With Treatment Resistant Depression in Older Adults (NCT02181231) | Washington University School of Medicine | 2016-06-01 |
| A Phase I Trial of SHR3162 in Subjects With Advanced Solid Tumors (NCT02759666) | Atridia Pty Ltd. | 2016-06-01 |
| Absorption and Systematic Pharmacokinetics of Topically Applied IDP-120 Gel (NCT02850003) | Bausch Health Americas, Inc. | 2016-06-01 |
| 3BNC117 and 10-1074 in HIV-infected Individuals (NCT02825797) | Rockefeller University | 2016-06-01 |
| Phase 1/2 Study of Mocetinostat and Durvalumab in Patients With Advanced Solid Tumors and NSCLC (NCT02805660) | Mirati Therapeutics Inc. | 2016-06-01 |
| Study to Assess the Safety, Tolerability, PK, ECG Effects, Food Effect, and Drug-drug Interaction (DDI) of Hormonal Contraceptives of PTI-428 in Healthy Female Volunteers (NCT02846142) | Proteostasis Therapeutics, Inc. | 2016-06-01 |
| CD22 Targeting CAR-T Therapy Against B Cell Hematological Malignancies (NCT02794961) | Kai Lin Xu; Jun Nian Zheng | 2016-06-01 |
| A Randomised Phase II Open-label Study With a Phase Ib Safety lead-in Cohort of ONCOS-102, an Immune-priming GM-CSF Coding Oncolytic Adenovirus, and Pemetrexed/Cisplatin in Patients With Unresectable Malignant Pleural Mesothelioma (NCT02879669) | Targovax Oy | 2016-06-01 |
| Human Umbilical Cord-Mesenchymal Stem Cells for Pneumoconiosis (NCT02790762) | Shenzhen Hornetcorn Bio-technology Company, LTD | 2016-06-01 |
| Autologous CMV-Specific Cytotoxic T Cells and Temozolomide in Treating Patients With Glioblastoma (NCT02661282) | M.D. Anderson Cancer Center | 2016-06-01 |
| Evaluation of Safety and Activity of an Anti-PDL1 Antibody (DURVALUMAB) Combined With CSF-1R TKI (PEXIDARTINIB) in Patients With Metastatic/Advanced Pancreatic or Colorectal Cancers (NCT02777710) | Centre Leon Berard | 2016-06-01 |
| Transcranial Direct Current Simulation in Chronic Migraine (NCT02817139) | Federal University of Paraíba | 2016-06-01 |
| A Phase 1/2 Study of AEB1102 in Patients With Arginase I Deficiency (NCT02488044) | Aeglea Biotherapeutics | 2016-06-01 |
| Safety and Feasibility of Intracoronary Hypothermia in Acute Myocardial Infarction (NCT02753478) | Catharina Ziekenhuis Eindhoven | 2016-06-01 |
| A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clear Cell Carcinoma (NCT02837991) | Celldex Therapeutics | 2016-06-01 |
| Endolaserless Vitrectomy With Intravitreal IAI for PDR-Related VH (NCT02976012) | Southeast Retina Center, Georgia | 2016-06-01 |
| Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I (NCT02811510) | Yale University | 2016-06-01 |
| The Efficacy of Severe Whitening and Delayed Fading in Acetic Acid-enhanced Endoscopy for Diagnosing Gastric Intestinal Metaplasia (NCT02806115) | Shandong University | 2016-06-01 |
| Autologous CD19 CAR T Cells in Relapsed or Refractory B-cell Lymphoma (NCT02842138) | Peking University | 2016-06-01 |
| Buccal Versus Injectable Naloxone: a Phase I Healthy Volunteer Study (NCT02733822) | King's College London | 2016-06-01 |
| Evaluation of CAR19 T-cells as an Optimal Bridge to Allogeneic Transplantation (NCT02431988) | University College, London | 2016-06-01 |
| A Study to Evaluate the Effect of IV Doses of Rivipansel on Subjects With Renal Impairment and in Healthy Subjects (NCT02813798) | GlycoMimetics Incorporated | 2016-06-01 |
| GVHD Prophylaxis With Post-transplantation Bendamustine in Refractory Leukemia (NCT02799147) | St. Petersburg State Pavlov Medical University | 2016-06-01 |
| Bioequivalence Study of Fulvestrant Injection 50 mg/mL in Healthy Post-menopausal Female Subjects (NCT02795039) | Fresenius Kabi | 2016-06-01 |
| Efficacy of Microneedling With Topical Vitamin C in Treatment of Acne Scarring (NCT03522922) | Sohag University | 2016-06-01 |
| A Clinical Study to Investigate the Effect of Gemfibrozil or Rifampicin on Blood Concentrations of Selexipag in Healthy Subjects (NCT02770222) | Actelion | 2016-06-01 |
| Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma (NCT02861898) | Northwell Health | 2016-06-01 |
| A Bioavailability Crossover Study of Two Formulations of Lamotrigine Extended Release Tablets in Healthy Subjects (NCT02821338) | Food and Drug Administration (FDA) | 2016-06-01 |
| A Phase 1 Safety Study in Adults With Schizophrenia (NCT02804568) | Alkermes, Inc. | 2016-06-01 |
| Clinical Study to Assess Body Fluid Homeostasis After Administration of ACT-132577 in Healthy Subjects (NCT02708004) | Idorsia Pharmaceuticals Ltd. | 2016-06-01 |
| Evaluation of the Effect of a Probiotic Supplement Upon Gastrointestinal Function (NCT02928484) | Biopolis S.L. | 2016-06-01 |
| Dose-escalation Study of GSK2330672 in Japanese Healthy Male Volunteers (NCT02801981) | GlaxoSmithKline | 2016-06-01 |
| Study to Assess the Bioequivalence of Ibrutinib 560- Milligram (mg) Tablet to Four 140 -mg IMBRUVICA Capsules (NCT02841150) | Janssen Research & Development, LLC | 2016-06-01 |
| A Study to Determine the Safety & Efficacy of ZPL-5212372 in Healthy Subjects and in Subjects With Atopic Dermatitis (NCT02795832) | Ziarco Pharma Ltd | 2016-06-01 |
| Interaction of Alcohol With Energy Drinks (NCT02771587) | Parc de Salut Mar | 2016-06-01 |
| Dimethylfumarate (DMF) in Relapsed/Refractory CLL/SLL (NCT02784834) | Michael Choi | 2016-06-01 |
| Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer (NCT02817113) | Orient Europharma Co., Ltd. | 2016-06-01 |
| A Multiple Ascending Dose Study of BPN14770 in Healthy Young and Elderly Male or Female Subjects (NCT02840279) | Tetra Discovery Partners | 2016-06-01 |
| T-Cell Therapy for Advanced Breast Cancer (NCT02792114) | Memorial Sloan Kettering Cancer Center | 2016-06-01 |
| Copanlisib in Association With Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinomas Harboring a PI3KCA Mutation/Amplification and/or a PTEN Loss (NCT02822482) | UNICANCER | 2016-06-01 |
| Efficacy and Safety of Paclitaxel-eluting Balloons for Below the Knee Peripheral Arterial Disease (NCT02772224) | Shanghai 10th People's Hospital | 2016-06-01 |
| Chidamide Plus DCAG for Relapsed/Refractory AML (NCT02886559) | Chinese PLA General Hospital | 2016-06-01 |
| Serial mpMRI (Multi Parametric Magnetic Resonance Imaging) Scanning in Prostate Cancer After Androgen Deprivation Therapy and RadioTherapy (NCT02721784) | University College, London | 2016-06-01 |
| Exploratory Study of BO-112 in Adult Patients With Aggressive Solid Tumors (NCT02828098) | Highlight Therapeutics | 2016-06-01 |
| Examination of Whether Host Preconditioning Modifies Short-term Transplant Survival (NCT01960764) | University of California, San Diego | 2016-06-01 |
| Intra-nasal Naloxone for Treatment of Impaired Awareness of Hypoglycemia (NCT02700048) | University of Minnesota | 2016-06-01 |
| Bevacizumab Therapy for Brain Arteriovenous Malformation (NCT02314377) | University of California, San Francisco | 2016-06-01 |
| Pharmacogenomics of GLP1 Receptor Agonists (NCT05762744) | University of Maryland, Baltimore | 2016-06-01 |
| Comparison of Two Dose Strengths of Selexipag in Healthy Adults (NCT02745860) | Actelion | 2016-06-01 |
| Safety Testing of Adding Nivolumab to Chemotherapy in Patients With Intermediate and High-Risk Local-Regionally Advanced Head and Neck Cancer (NCT02764593) | RTOG Foundation, Inc. | 2016-06-01 |
| A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder) (NCT02807675) | Acorda Therapeutics | 2016-06-01 |
| UCMSC Transplantation in the Treatment of Cartilage Damage (NCT02776943) | South China Research Center for Stem Cell and Regenerative Medicine | 2016-06-01 |
| A Study to Determine the Efficacy, Safety and Pharmacokinetics of GMI-1271 as Adjunct to Standard of Care for the Treatment of Multiple Myeloma (NCT02811822) | GlycoMimetics Incorporated | 2016-06-01 |
| A Study to Assess the Relative Bioavailability And Food Effect of a Tablet Formulation of GDC-0276 in Healthy Participants (NCT02856152) | Genentech, Inc. | 2016-06-01 |
| Cell Proliferation in Pulmonary Hypertension. FDG-PET Comparison Between Patients and Healthy Subjects (NCT02886793) | Joan Albert Barbera Mir | 2016-06-01 |
| Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction (NCT02567396) | National Cancer Institute (NCI) | 2016-06-01 |
| Pharmacokinetics and Safety of HCP1105 and Co-administration of HGP0918, HGP0816 in Healthy Male Volunteers (NCT02941796) | Hanmi Pharmaceutical Company Limited | 2016-06-01 |
| A Study of GDC-0134 to Determine Initial Safety, Tolerability, and Pharmacokinetic Parameters in Participants With Amyotrophic Lateral Sclerosis (NCT02655614) | Genentech, Inc. | 2016-05-31 |
| Safety and Tolerability of GemRIS 225 mg in Subjects With Muscle-Invasive Bladder Cancer (NCT02722538) | Taris Biomedical LLC | 2016-05-31 |
| Evaluation of Innovative Tools in Development of Antibiotics (NCT03177720) | Medical University of Vienna | 2016-05-29 |
| Drug-drug Interaction Study Between UIC201601 and UIC201602 (NCT05190133) | Korea United Pharm. Inc. | 2016-05-28 |
| Vedolizumab (Anti-alpha4beta7) in Subjects With HIV Infection Undergoing Analytical Treatment Interruption (NCT02788175) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-05-28 |
| Safety, Tolerability, and Pharmacokinetics of SAB-301 in Healthy Adults (NCT02788188) | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-05-28 |
| Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of Compound PF-06823859 (NCT02766621) | Pfizer | 2016-05-27 |
| Safety and Pharmacokinetics of UV-4B Solution Administered Orally as Multiple Ascending Doses to Healthy Subjects (NCT02696291) | Emergent BioSolutions | 2016-05-27 |
| Study of Safety, Tolerability, and Pharmacokinetics of REGN3470-3471-3479 in Healthy Adult Volunteers (NCT02777151) | Regeneron Pharmaceuticals | 2016-05-27 |
| Lenvatinib and Weekly Paclitaxel for Patients With Recurrent Endometrial or Ovarian Cancer (NCT02788708) | Floor Backes | 2016-05-27 |
| A Study to Investigate the Effect of Itraconazole and Rifampin on Pharmacokinetics (PK) of Vemurafenib at Steady State (NCT02608034) | Genentech, Inc. | 2016-05-26 |
| Phase I Study of BAY1436032 in IDH1-mutant Advanced Solid Tumors (NCT02746081) | Bayer | 2016-05-26 |
| Study to Evaluate the Effect of Food on the Pharmacokinetics of a BGB-3111 in Healthy Subjects (NCT04163523) | BeiGene | 2016-05-25 |
| Nanogen Pegfilgrastim (Pegcyte) PK/PD Clinical Study in Breast Cancer Patients (NCT03376503) | Nanogen Pharmaceutical Biotechnology Joint Stock Company | 2016-05-25 |